Charles J. Ferro

2024 ESC Guidelines for the management of elevated blood pressure and hypertension

John W. McEvoy, Cian P. McCarthy, Rosa María Bruno et al. · European Heart Journal · 2024 · 2K citations · Full text

Medicine, Cardiology, Internal Medicine +14

Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in Humans

William G. Haynes, Charles J. Ferro, Kevin P.J. O’Kane et al. · Circulation · 1996 · 321 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease

Nicola C. Edwards, Richard P. Steeds, Paul M. Stewart et al. · Journal of the American College of Cardiology · 2009 · 281 citations

Medicine, Cardiology, Physiology +12

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Pantelis Sarafidis, Charles J. Ferro, Enrique Morales et al. · Nephrology Dialysis Transplantation · 2019 · 204 citations

Medicine, Endocrinology, Pharmacology +17

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Giuseppe Boriani, Irina Savelieva, Gheorghe‐Andrei Dan et al. · EP Europace · 2015 · 185 citations · Full text

Medicine, Cardiology, Nephrology +17